AWM Investment Co. Amends APDN Stake, Maintains Significant Position
Ticker: BNBX · Form: SC 13G/A · Filed: Jan 10, 2024 · CIK: 744452
| Field | Detail |
|---|---|
| Company | Applied Dna Sciences INC (BNBX) |
| Form Type | SC 13G/A |
| Filed Date | Jan 10, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investor
TL;DR
**AWM Investment Co. is still a big owner of APDN, signaling continued institutional interest.**
AI Summary
AWM Investment Company, Inc. and its associated entities, including Adam Stettner and David Greenhouse, filed an amended SC 13G/A on January 10, 2024, indicating their beneficial ownership in Applied DNA Sciences, Inc. (APDN) as of December 31, 2023. This amendment updates their previous filing, confirming their continued significant stake in the company. This matters to investors because AWM is a major institutional holder, and their continued position suggests a long-term belief in APDN's prospects, potentially signaling stability or future growth to other shareholders.
Why It Matters
This filing confirms a major institutional investor, AWM Investment Company, Inc., continues to hold a significant stake in Applied DNA Sciences, Inc., which can influence market perception and investor confidence.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, indicating no new major changes in ownership that would introduce significant risk.
Analyst Insight
Investors should note that a significant institutional holder, AWM Investment Company, Inc., continues to maintain its position in Applied DNA Sciences, Inc. This suggests ongoing confidence from a major player, which could be a positive signal, but further analysis of AWM's specific investment thesis and APDN's fundamentals is warranted before making investment decisions.
Key Players & Entities
- AWM Investment Company, Inc. (company) — filer and beneficial owner
- Applied DNA Sciences, Inc. (company) — subject company (issuer)
- Adam Stettner (person) — group member associated with AWM
- David Greenhouse (person) — group member associated with AWM
- MG Advisers, L.L.C. (company) — group member associated with AWM
FAQ
What type of filing is this and what does it generally indicate?
This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It indicates that a passive institutional investor or group has updated their beneficial ownership stake in a public company, in this case, Applied DNA Sciences, Inc.
Who are the primary entities involved in this filing?
The primary filing entity is AWM Investment Company, Inc., and the subject company is Applied DNA Sciences, Inc. Other group members include Adam Stettner, David Greenhouse, MG Advisers, L.L.C., and several 'Special Situations' funds.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as stated in the filing.
What is the CUSIP number for Applied DNA Sciences, Inc.'s securities mentioned in the filing?
The CUSIP number for Applied DNA Sciences, Inc.'s Common Stock, Par Value $0.001, is 03815U300, according to the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 10, 2024 by Adam Stettner regarding APPLIED DNA SCIENCES INC (BNBX).